Drug-target network of taxanes revealed by data mining.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pakistan Journal of Pharmaceutical Sciences

• Publication date

  2018-03-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  PMID 29618439
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis

  2014cited by this paper
• Predicting Protein-Ligand Interactions Based on Chemical Preference Features with its Application to New D-Amino Acid Oxidase Inhibitor Discovery

  2014cited by this paper
• Cellular and clinical pharmacology of the taxanes docetaxel and paclitaxel – a review

  2014cited by this paper
• Polypharmacology: challenges and opportunities in drug discovery.

  2014cited by this paper
• Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach.

  2014cited by this paper
• Network analysis of team communication in a busy emergency department

  2013cited by this paper
• STITCH 4: integration of protein–chemical interactions with user data

  2013influential reference
• Visual Data Mining of Biological Networks: One Size Does Not Fit All

  2013cited by this paper
• Target network analysis of adiponectin, a multifaceted adipokine

  2013influential reference
• Topological analysis and interactive visualization of biological networks and protein structures

  2012cited by this paper
• A travel guide to Cytoscape plugins

  2012influential reference
• Update on taxane development: new analogs and new formulations

  2012cited by this paper
• STITCH 3: zooming in on protein–chemical interactions

  2011cited by this paper
• An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics

  2011cited by this paper
• Hub Promiscuity in Protein-Protein Interaction Networks

  2010cited by this paper
• Building a drug–target network and its applications

  2009cited by this paper
• Target discovery from data mining approaches.

  2009influential reference
• The dual role of thymidine phosphorylase in cancer development and chemotherapy

  2009cited by this paper
• STITCH 2: an interaction network database for small molecules and proteins

  2009cited by this paper
• Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancer.

  2008cited by this paper
• Computing topological parameters of biological networks

  2008cited by this paper
• Network pharmacology: the next paradigm in drug discovery.

  2008cited by this paper
• Drug—target network

  2007cited by this paper
• Mechanism of multidrug recognition by MDR1/ABCB1.

  2007cited by this paper
• Network pharmacology

  2007cited by this paper
• STITCH: interaction networks of chemicals and proteins

  2007cited by this paper
• Recent Advances in the New Generation Taxane Anticancer Agents

  2005cited by this paper
• Targeted inhibition of transient activation of the EGFR-mediated cell survival pathway enhances paclitaxel-induced ovarian cancer cell death.

  2005cited by this paper
• Network biology: understanding the cell's functional organization

  2004cited by this paper
• Epidermal growth factor receptor: mechanisms of activation and signalling.

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• The epidermal growth factor receptor as a target for cancer therapy.

  2001cited by this paper

• No citing papers are available for this paper.